Search results
13 mar 2018 · Memantine (MEM), an antagonist of extrasynaptic NMDAR, is currently used for the treatment of AD jointly with acetylcholinesterase inhibitors.
- Memantine, Donepezil, or Combination Therapy—What is the best therapy ...
All four treatment regimens were well tolerated by most...
- Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
Memantine, an NMDA receptor antagonist has been found to be...
- Memantine, Donepezil, or Combination Therapy—What is the best therapy ...
Memantine is a prescription drug that can help with memory loss and other symptoms of dementia. It works differently for everyone and may take up to 3 months to work fully. Learn about its side effects, dosage and types.
10 wrz 2020 · All four treatment regimens were well tolerated by most patients. Memantine was the best‐tolerated medication, followed by placebo and the combination of memantine plus donepezil. Donepezil was the least tolerable.
2 mar 2007 · Memantine, an NMDA receptor antagonist has been found to be effective, both as monotherapy and in combination with donepezil, in the treatment of patients with moderate to severe stage AD.
consider memantine for patients with moderate Alzheimer’s Disease and offer memantine for people with severe Alzheimer’s Disease, and if the person is already taking acetylcholinesterase inhibitors primary care prescribers may start treatment with memantine without taking advice from a specialist.
Memantine is the only FDA-approved drug for the treatment of Alzheimer's disease that is not an acetyl cholinesterase inhibitor. The drug is a noncompetitive, low- to medium-affinity antagonist of NMDA glutamate receptors in the brain.
28 sie 2024 · Namenda (memantine) reduces the actions of chemicals in the brain that may contribute to the symptoms of Alzheimer's disease. Namenda is used to treat moderate to severe dementia of the Alzheimer's type. Namenda's mechanism of action is to help balance a brain chemical called glutamate.
